MULTIFLEX
Dead / Abandoned — Abandoned — failure to respond (as of 20 Sept 2022)
What this means for you
This application is over — abandoned 08 Sept 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 79326368
- Mark type
- Stylized text
- Filed
- 19 May 2021
- Abandoned
- 08 Sept 2022
Goods and services
- Class 005 — Pharmaceuticals: Medical and veterinary preparations and articles; plasters, materials for dressings; medical dressings, coverings and applicators (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); surgical dressings; wound dressings; occlusive wound dressings; adhesive wound dressings; wound healing preparations; gauzes for medical and surgical use; wound healing dressings; impregnated pads containing medicated preparations; antimicrobial, antibacterial and antiseptic preparations; dressings impregnated with antimicrobial, antibacterial and antiseptic preparations; disinfectant dressings; sterilized dressings; adhesive dressings and patches for medical purposes; transdermal patches; haemostatic wound dressings
Owner
Prosecution history
- 26 Sept 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 10 Oct 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 20 Sept 2023 — FINAL DISPOSITION NOTICE SENT TO IB
- 20 Sept 2023 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 16 May 2023 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 26 Apr 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 26 Apr 2023 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 20 Sept 2022 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 20 Sept 2022 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 20 Sept 2022 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 27 Mar 2022 — REFUSAL PROCESSED BY IB
- 07 Mar 2022 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 07 Mar 2022 — REFUSAL PROCESSED BY MPU
- 04 Feb 2022 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 03 Feb 2022 — NON-FINAL ACTION WRITTEN